Farmacogenética aplicada al tratamiento de la leucemia linfoide aguda

Prado Vizcaíno, Yalena; Arencibia Núñez, Alberto; Vizcaíno Londian, María de los A; Abeledo García, Carlos Manuel; Rodeiro Guerra, Idania.
Rev. cuba. hematol. inmunol. hemoter ; 27(3): 283-290, jul.-set. 2011.
Artículo en Español | LILACS | ID: lil-615356

Documentos relacionados

  1. Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel.
  2. Modulation of CD19 surface expression in B cell acute lymphoblastic leukemia.
  3. [Application of genome editing technology for the validation of pharmacogenomics in acute lymphoblastic leukemia].
  4. [Experience with an international study on standard-risk relapsed childhood acute lymphoblastic leukemia (IntReALL SR 2010 study) in Japan].
  5. Management of ALL in adults: 2024 ELN recommendations from a European expert panel.
  6. The Snowstorm.
  7. The Philadelphia Chromosome, from Negative to Positive: A Case Report of Relapsed Acute Lymphoblastic Leukemia Following Allogeneic Stem Cell Transplantation.
  8. Single-cell analysis of acute lymphoblastic and lineage-ambiguous leukemia: approaches and molecular insights.
  9. Infant Acute Lymphoblastic Leukemia-New Therapeutic Opportunities.
  10. Genetic Profiling in Children With Acute Lymphoblastic Leukemia Referred for Allogeneic Hematopoietic Stem Cell Transplantation.